Log In
BCIQ
Print this Print this
 

ONL1204

  Manage Alerts
Collapse Summary General Information
Company ONL Therapeutics Inc.
Description 
Molecular Target Fas receptor (CD95)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today